Trial Profile
A Study to Evaluate the Relationship Between Baseline Peripheral Blood Epstein-Barr virus (EBV) Load and Treatment Response to Rituximab in Rheumatoid Arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 May 2016 New trial record